Evidence map›Paper›PMID 41777982›Full record

ArticleCureus2026

Maternal and Fetal Outcomes in Early-Onset vs. Late-Onset Preeclampsia: A Retrospective Study at a Tertiary Care Institute in India.

Uditi S Harjai, Ketaki K Junnare

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Uditi S HarjaiObstetrics and Gynaecology, Smt. Kashibai Navale Medical College and General Hospital, Pune, IND.
Ketaki K JunnareObstetrics and Gynaecology, Smt. Kashibai Navale Medical College and General Hospital, Pune, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Preeclampsia is a hypertensive disorder of pregnancy associated with significant maternal and perinatal morbidity and mortality. Distinguishing between early- and late-onset preeclampsia is crucial due to differences in pathophysiology, severity, and outcomes. This study aimed to evaluate and contrast clinical characteristics, complications, and outcomes between the two types. Aim & objective The aim of the study is to compare the maternal and fetal outcomes in pregnancies complicated by early-onset preeclampsia (before 34 weeks) versus late-onset preeclampsia (34 weeks or later) and identify specific clinical risks and prognostic implications associated with the timing of disease onset. Materials & methods A hospital-based retrospective observational study was conducted at Smt. Kashibai Navale Medical College and General Hospital, Pune, from November 2022 to October 2024. A total of 88 pregnant women diagnosed with preeclampsia were categorized into early-onset (<34 weeks) and late-onset (≥34 weeks) groups. Clinical data were extracted from medical records and analyzed using chi-square and Fisher's exact tests to assess associations between disease onset and maternal/neonatal outcomes. Results Among the 88 cases, early-onset and late-onset preeclampsia were nearly evenly distributed (48.9% vs. 51.1%). Severe preeclampsia was significantly more frequent in the early-onset group (93.0% vs. 62.2%, p=0.001). Early-onset preeclampsia was strongly associated with the cases who underwent IVF (in vitro fertilization) treatment (p=0.001). Early-onset cases had significantly higher rates of preterm delivery (<34 weeks: 76.7%), extremely low birth weight (<1.5 kg: 65.1%), intrauterine death (20.9%, p=0.002), NICU (Neonatal Intensive Care Unit) admissions (p<0.001), and low APGAR scores (p<0.001). Maternal complications were more frequent in early-onset cases, although the difference was not statistically significant. Discussion The study affirms that early-onset preeclampsia is associated with great severity disease and significantly poorer neonatal outcomes, especially in terms of prematurity, fetal growth restriction, and neonatal morbidity. IVF emerged as a notable risk factor for early-onset pre-eclampsia. Despite higher complication rates, maternal mortality was zero in this cohort. Conclusion Early-onset preeclampsia poses greater risks to both mother and fetus than late-onset disease. Identifying high-risk pregnancies, especially IVF conceptions, and implementing timely interventions are essential to improving outcomes. Enhanced surveillance and preparedness of neonatal intensive care are particularly critical in early-onset cases.

Indexed as

fetal developmentmaternal healthneonatal outcomespreeclampsiapregnancy complications

Identifiers

PMID41777982
PMCPMC12952277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.